Received Aug 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Y019318 | — |
No additional AE; HCP reporting that a patient received a dose of improperly stored VARIVAX.; This spontaneous report was received from a health professional and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 02-JUL-2025, the patient was vaccinated with an improperly storage of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX), as a dose of 0.5 ml (route of administration and anatomical location was not reported, lot number Y019318, which was verified to be valid, and expiration date on 21-NOV-2026) (0.5mL) for prophylaxis, the vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT), (lot number and expiration date not reported.). The administered dose of the vaccine experienced a temperature excursion 52.2 degrees Fahrenheit for unknown minutes, it was not reported if the information was recorded by a data logger or not. There was no adverse effect reported.
Sterile diluent